The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Applied Regression Analysis and Other Multivariable Methods
Walker, E. (1989) · Technometrics · doi:10.1080/00401706.1989.10488486 · Cited by 8,538
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
Statistical Methods for Rates and Proportions.
Plewis, I., & Fleiss, J. L. (1982) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982107 · Cited by 1,731
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., et al. (1983) · Nature · doi:10.1038/301214a0 · Cited by 1,243
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Verstraete, M., Bory, M., Collen, D., Erbel, R., Lennane, R. J., Mathey, D., Michels, H. R., Schartl, M., Uebis, R., Bernard, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92208-1 · Cited by 750
HULL, R. D., HIRSH, J., CARTER, C. J., JAY, R. M., DODD, P. E., OCKELFORD, P. A., COATES, G., GILL, G. J., TURPIE, A. G., DOYLE, D. J., et al. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-891 · Cited by 645
Self-citationJb, B., & Gj, R. (1964) · PubMed · Cited by 507
Verstraete, M., Miller, G. A., Bounameaux, H., Charbonnier, B., Colle, J. P., Lecorf, G., Marbet, G. A., Mombaerts, P., & Olsson, C. G. (1988) · Circulation · doi:10.1161/01.cir.77.2.353 · Cited by 401
Collen, D., Topol, E. J., Tiefenbrunn, A. J., Gold, H. K., Weisfeldt, M. L., Sobel, B. E., Leinbach, R. C., Brinker, J. A., Ludbrook, P. A., & Yasuda, I. (1984) · Circulation · doi:10.1161/01.cir.70.6.1012 · Cited by 378
Goldhaber, S., Heit, J., Sharma, G. V. R. K., Nagel, J. S., Kim, D., Parker, J. A., Drum, D., Reagan, K., Anderson, J., Kessler, C., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92354-9 · Cited by 367
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
Neuhaus, K.-L., Feuerer, W., Jeep-Tebbe, S., Niederer, W., Vogt, A., & Tebbe, U. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90399-9 · Cited by 298
POTASSIUM CHLORIDE AND INTESTINAL ULCERATION.
Ah, B., & Schoenaker, A. H. (1965) · PubMed · Cited by 260
Teger‐Nilsson, A. ‐., Friberger, P., & Gyzander, E. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091499 · Cited by 201
IMPROVED PRIMARY RENAL ALLOGRAFT SURVIVAL ON CYCLOSPORIN LIMITED TO WOMEN WITH PREVIOUS PREGNANCIES
HUISMAN, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91003-9 · Cited by 159
Levine, M., Goldhaber, S. Z., Gore, J. M., Hirsh, J., & Califf, R. M. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.291s · Cited by 136
Self-citationAgnelli, G., Buchanan, M. R., Fernandez, F., Boneu, B., van Ryn, J., Hirsh, J., & Collen, D. (1985) · Circulation · doi:10.1161/01.cir.72.1.178 · Cited by 99
Self-citationTissue plasminogen activator in thrombolytic therapy
(1987) · European Journal of Medicinal Chemistry · doi:10.1016/0223-5234(87)90281-9 · Cited by 75
Agnelli, G., Buchanan, M. R., Fernandez, F., et al. (1985) · Thrombosis Research · doi:10.1016/0049-3848(85)90314-7 · Cited by 59
Dalen, J. E., Paraskos, J. A., Ockene, I. S., Alpert, J. S., & Hirsh, J. (1986) · CHEST Journal · doi:10.1378/chest.89.5_supplement.370s · Cited by 59
Self-citationFennerty, A. G., Levine, M., & Hirsh, J. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.88s · Cited by 45
Self-citationTissue-Type Plasminogen Activator
Collen, D. (1986) · Drugs · doi:10.2165/00003495-198631010-00001 · Cited by 44
THROMBOLYTIC THERAPY IN VENOUS THROMBOEMBOLISM
Goldhaber, S. Z. (1995) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)01094-7 · Cited by 38
Research works printed but not linked: 10
- 1970, Phase I results, JAMA, 214, 2163
- 1974, Phase II results, JAMA, 229, 1606
- Goldhaber, 1986, Acute pulmonary embolism treated with tissue plasminogen activator, Lancet, 2, 886, 10.1016/S0140-6736(86)90411-3 · doi:10.1016/s0140-6736(86)90411-3
- Agnelli, 1985, Sustained thrombolysis with DNA-recombinant tissue-type plasminogen activator in rabbits, Blood, 66, 399, 10.1182/blood.V66.2.399.399 · doi:10.1182/blood.v66.2.399.399
- Shiffman, 1988, Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimens, Circulation, 19, 214, 10.1161/01.CIR.78.1.214 · doi:10.1161/01.cir.78.1.214
- 1973, Perfusion lung scanning, Circulation, 47, 46
- Parker, 1988, Pulmonary perfusion after rt-PA therapy for actue embolism: early improvement assessed with segmental perfusion scanning, Radiology, 166, 441, 10.1148/radiology.166.2.3122266 · doi:10.1148/radiology.166.2.3122266
- Verstraete, 1989, Bolus alteplase, Lancet, 2, 989, 10.1016/S0140-6736(89)91004-0 · doi:10.1016/s0140-6736(89)91004-0
- Tebbe, 1989, Single bolus injection of recombinant tissue-type plasminogen activator (rt-PA) in acute myocardial infarction, Am J Cardiol, 64, 448, 10.1016/0002-9149(89)90419-0 · doi:10.1016/0002-9149(89)90419-0
- Smalling, 1990, Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction. Results of a multicentre randomized trial of two dosage regimens, J Am Coll Cardiol, 15, 915, 10.1016/0735-1097(90)90216-C · doi:10.1016/0735-1097(90)90216-c
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., Bengel, F., Brady, A. J. B., Ferreira, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn310 · Cited by 2,826
Jaff, M. R., McMurtry, M. S., Archer, S. L., Cushman, M., Goldenberg, N., Goldhaber, S. Z., Jenkins, J. S., Kline, J. A., Michaels, A. D., Thistlethwaite, P., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214914f · Cited by 2,229
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Metadata
- Authors
- Levine, M., Hirsh, J., Weitz, J., Cruickshank, M., Neemeh, J., Turpie, A. G., & Gent, M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1990-12
- Volume
- 98
- Issue
- 6
- Pages
- 1473-1479
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2041176958
- Cited by
- 308
- References
- 27
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.